MSD Animal Health launches first systemic treatment for poultry red mites

MSD Animal Health announced Sept. 5 the launch of Exzolt, the first systemic treatment for poultry red mite infestations - a novel approach that virtually eliminates poultry red mites in production houses of any size or type, including free range.

MSD Animal Health (known as Merck Animal Health within the United States and Canada) announced Sept. 5 the launch of Exzolt (fluralaner), the first systemic treatment for poultry red mite infestations – a novel approach that virtually eliminates poultry red mites in production houses of any size or type, including free range. Conveniently administered via drinking water, Exzolt also improves poultry welfare by reducing stress associated with other forms of treatment, and minimizes the exposure of workers and birds to chemical sprays.

“Poultry red mites are among the most threatening pests in Europe, contributing to increased stress levels, decreased weight gain and diminished egg quality and production in infested birds,” says Dr. Taylor Barbosa, DVM, PhD, ACPV, Head of Poultry, MSD Animal Health. “It is important to effectively treat poultry red mites as infestations not only affect the birds’ welfare, but also result in significant economic losses for poultry producers.”

Poultry red mites are a top five cause of economic loss in European layer and breeder operations and in many other countries, as infestations cause significant stress to poultry, decrease reproductive potential in males, egg production in females and weight gain in young birds. The total annual cost of poultry red mite infestations in the  European egg laying industry is estimated  to be €360 million, with more than 430 million hens in all production types – pullets, breeders and layer hens – suffering from infestations.

Poultry red mites are nocturnal feeders that hide during the day under manure, on roosts and in cracks and crevices in the chicken house, where they lay eggs, making them difficult to eliminate. Previously available treatment options are labor-intensive and/or have achieved limited success in eliminating or controlling infestations. Mite infestations affect poultry workers as well, causing gamasoidosis, a skin condition characterized by rash and itching.

The safety of Exzolt has been established through comprehensive clinical research studies. These studies demonstrated that Exzolt virtually eliminates poultry red mites in production houses, and is safe for the birds and for human handling. No significant adverse events were reported.

“With a zero day withdrawal period, eggs from chickens treated with Exzolt are safe to consume, making Exzolt ideal for maintaining the health, performance and welfare of flocks while continuing to meet market demands and avoiding economic loss for producers,” adds Dr. Barbosa.

Page 1 of 358
Next Page